# Nuwellis, Inc.: filings

NUWE · Nasdaq · CIK 1506492 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nuwe.md) · [Financials](/companies/nuwe/financials.md) · [Filings](/companies/nuwe/filings.md) · [Insiders](/companies/nuwe/insiders.md)

## Reports and events: 405 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 272, 8-K 252, CORRESP 54, 3 45, 10-Q 44, S-1/A 38, SC 13G/A 28, EFFECT 27, 424B4 25, UPLOAD 25, DEF 14A 23, SC 13G 23, 424B5 20, D 20, S-1 19, 10-K 15, S-8 14, 424B3 13, SD 13, PRE 14A 12, 4/A 7, 5 7, DEFA14A 7, FWP 7, S-3 7, SCHEDULE 13G 7, 3/A 6, 8-K/A 6, S-1MEF 6, 10-12B/A 5, 5/A 5, ARS 5, SC 13D/A 4, PRER14A 3, SCHEDULE 13G/A 3, 10-K/A 2, DEFR14A 2, DRS 2, POS AM 2, S-3/A 2, 10-12B 1, 8-A12B 1, AW 1, CERTNAS 1, CT ORDER 1, POS462C 1, S-3MEF 1, SC 13D 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 09:18 ET | [8-K](/filings/0001140361-26-040605.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-26-040605 |
| 2026-08-26 | 21:26 ET | [8-K](/filings/0001140361-26-034367.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-034367 |
| 2026-08-13 | 16:38 ET | [8-K](/filings/0001140361-26-032838.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-032838 |
| 2026-08-13 | 16:06 ET | [10-Q](/filings/0001140361-26-032810.md) | Quarterly report, period 2026-06-30 | 0001140361-26-032810 |
| 2026-08-03 | 16:35 ET | [8-K](/filings/0001140361-26-030985.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-030985 |
| 2026-07-24 | 16:15 ET | [8-K](/filings/0001140361-26-029609.md) | 5.07 Shareholder vote results | 0001140361-26-029609 |
| 2026-07-07 | 16:30 ET | [DEF 14A](/filings/0001539497-26-001914.md) | Proxy statement, period 2026-07-07 | 0001539497-26-001914 |
| 2026-06-24 | 17:47 ET | [8-K](/filings/0001140361-26-026114.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-26-026114 |
| 2026-06-18 | 17:59 ET | [8-K](/filings/0001140361-26-025614.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-025614 |
| 2026-06-10 | 09:09 ET | [8-K](/filings/0001140361-26-024740.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-024740 |
| 2026-06-04 | 13:04 ET | [S-1/A](/filings/0001140361-26-023964.md) | Registration statement, amended | 0001140361-26-023964 |
| 2026-05-29 | 17:28 ET | [S-1/A](/filings/0001140361-26-023354.md) | Registration statement, amended | 0001140361-26-023354 |
| 2026-05-22 | 17:09 ET | [S-1](/filings/0001140361-26-022629.md) | Registration statement | 0001140361-26-022629 |
| 2026-05-15 | 16:01 ET | [10-Q](/filings/0001140361-26-021649.md) | Quarterly report, period 2026-03-31 | 0001140361-26-021649 |
| 2026-05-12 | 16:04 ET | [8-K](/filings/0001140361-26-020805.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-020805 |
| 2026-04-29 | 16:30 ET | [8-K](/filings/0001140361-26-017826.md) | 5.07 Shareholder vote results | 0001140361-26-017826 |
| 2026-04-24 | 17:00 ET | [8-K](/filings/0001140361-26-016755.md) | 8.01 Other events | 0001140361-26-016755 |
| 2026-04-02 | 17:01 ET | [DEF 14A](/filings/0001539497-26-001081.md) | Proxy statement, period 2026-04-28 | 0001539497-26-001081 |
| 2026-04-01 | 16:45 ET | [8-K/A](/filings/0001140361-26-012781.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-012781 |
| 2026-03-27 | 16:55 ET | [8-K](/filings/0001140361-26-011775.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-011775 |
| 2026-03-17 | 09:13 ET | [8-K](/filings/0001140361-26-009745.md) | 8.01 Other events | 0001140361-26-009745 |
| 2026-03-11 | 17:24 ET | [10-K](/filings/0001140361-26-009080.md) | Annual report, period 2025-12-31 | 0001140361-26-009080 |
| 2026-03-10 | 16:02 ET | [8-K](/filings/0001140361-26-008781.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-008781 |
| 2026-02-26 | 08:49 ET | [8-K](/filings/0001140361-26-006888.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-006888 |
| 2026-01-30 | 09:08 ET | [8-K](/filings/0001140361-26-002906.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-002906 |
| 2026-01-23 | 17:02 ET | [8-K](/filings/0001140361-26-002241.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-002241 |
| 2025-11-12 | 16:19 ET | [10-Q](/filings/0001140361-25-041651.md) | Quarterly report, period 2025-09-30 | 0001140361-25-041651 |
| 2025-11-12 | 11:49 ET | [8-K](/filings/0001140361-25-041591.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-041591 |
| 2025-10-08 | 17:10 ET | [8-K](/filings/0001140361-25-037713.md) | 5.02 Departure or appointment of officers or directors | 0001140361-25-037713 |
| 2025-09-30 | 08:55 ET | [8-K](/filings/0001140361-25-036651.md) | 8.01 Other events | 0001140361-25-036651 |
| 2025-09-18 | 09:18 ET | [8-K](/filings/0001140361-25-035346.md) | 8.01 Other events | 0001140361-25-035346 |
| 2025-09-09 | 09:20 ET | [8-K](/filings/0001140361-25-034368.md) | 8.01 Other events | 0001140361-25-034368 |
| 2025-09-03 | 08:55 ET | [8-K](/filings/0001140361-25-033738.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-25-033738 |
| 2025-08-21 | 08:55 ET | [8-K](/filings/0001140361-25-032150.md) | 8.01 Other events | 0001140361-25-032150 |
| 2025-08-19 | 08:52 ET | [8-K](/filings/0001140361-25-031828.md) | 8.01 Other events | 0001140361-25-031828 |
| 2025-08-14 | 16:03 ET | [10-Q](/filings/0001140361-25-031209.md) | Quarterly report, period 2025-06-30 | 0001140361-25-031209 |
| 2025-08-14 | 11:01 ET | [8-K](/filings/0001140361-25-031093.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-031093 |
| 2025-08-04 | 17:15 ET | [8-K](/filings/0001140361-25-028670.md) | 5.07 Shareholder vote results | 0001140361-25-028670 |
| 2025-07-23 | 08:50 ET | [8-K](/filings/0001140361-25-026855.md) | 8.01 Other events | 0001140361-25-026855 |
| 2025-07-14 | 08:55 ET | [DEF 14A](/filings/0001539497-25-001825.md) | Proxy statement, period 2025-08-04 | 0001539497-25-001825 |
| 2025-07-02 | 08:49 ET | [8-K](/filings/0001140361-25-024517.md) | 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-25-024517 |
| 2025-06-23 | 16:40 ET | [8-K](/filings/0001140361-25-023368.md) | 3.01 Delisting notice | 0001140361-25-023368 |
| 2025-06-16 | 20:30 ET | [SCHEDULE 13D](/filings/0001140361-25-022709.md) | Ownership report, active investor | 0001140361-25-022709 |
| 2025-06-09 | 09:11 ET | [8-K](/filings/0001140361-25-021870.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-25-021870 |
| 2025-06-03 | 20:42 ET | [S-1/A](/filings/0001140361-25-021187.md) | Registration statement, amended | 0001140361-25-021187 |
| 2025-05-30 | 09:26 ET | [S-1](/filings/0001140361-25-020878.md) | Registration statement | 0001140361-25-020878 |
| 2025-05-22 | 16:40 ET | [8-K](/filings/0001140361-25-020182.md) | 5.07 Shareholder vote results | 0001140361-25-020182 |
| 2025-05-13 | 17:00 ET | [10-Q](/filings/0001140361-25-018676.md) | Quarterly report, period 2025-03-31 | 0001140361-25-018676 |
| 2025-05-13 | 11:00 ET | [8-K](/filings/0001140361-25-018543.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-018543 |
| 2025-05-12 | 16:45 ET | [8-K](/filings/0001140361-25-018404.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-25-018404 |

Page 1 of 9. [Older](/companies/nuwe/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.